pneumococcal conjugate vaccinehospitalizationcostWe report substantial declines in all-cause pneumonia hospitalizations and related costs after introduction of pneumococcal conjugate vaccines in Ontario, Canada. We observed reduced hospitalizations in both vaccinated and unvaccinated age groups, supporting the ...
Get the latest COVID vaccine and stay updated with your boosters LOOK: Counties with the highest cancer rates in New York LOOK: Counties with the highest cancer rates in New York Stackerranked the counties with the highest cancer rates in New York using data from the CDC. Gallery Credit: St...
An infection that inflames the air sacs in the lungs, pneumonia is a fairly common illness. The condition is characterized by fever, chills, difficulty breathing, and coughing. In some cases, the air sacs fill with fluid or pus, making the condition more dangerous. ...
Other common risk factors of a severe respiratory viral infection among the elderly include underlying medical conditions and poor response to influenza vaccine [12, 13]. In adults, mixed infections with a respiratory virus and a bacterial pathogen, especially rhinovirus with pneumococci, have been ...
(H1N1)pdm09. Serum samples were tested in duplicate at an initial dilution of 1:10 and a final dilution of 1:1280. Suitable control serum samples were included in all analyses; post-infection ferret serum samples raised against the five vaccine strains used in the analysis, served as ...
Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa Article Open access 25 May 2023 Polyclonal anti-whole cell IgY passive immunotherapy shields against P. aeruginosa-induced acute pneumonia and burn wound infections in murine models Articl...
vaccine in the USA (63.6% of adults of ≥65 years of age, compared with pneumococcal vaccination rates of 20% to 30% in most European countries15,16); in addition, in 2015 in the USA, ~69% of adults of ≥65 years of age had received an influenza vaccine within the previous 12 ...
To date, influenza is the only common respiratory virus for which a vaccine is available. Immunisation remains the cornerstone of influenza prevention [6]. The immunogenicity of the inactivated influenza vaccine is lower in patients with HM compared with immunocompetent controls [167–172]. A second...
The evaluation of vaccine efficacy, and the interpretation of trial results, is compli- cated by the nature of bovine respiratory disease, and in particular the multitude of pathogens and environmental stressors that contribute to disease development. Addi- tionally, the disease pattern of pneumonia...
All-cause, cause-specific and age-specific standardised mortality ratios of patients with systemic lupus erythematosus in Ontario, Canada over 43 years (1971–2013). Ann Rheum Dis. 2019;78(6):802–6. Article PubMed Google Scholar Yurkovich M, Vostretsova K, Chen W, Aviña-Zubieta JA. ...